Get startedLog in
    Picture of CNS Pharmaceuticals logo

    CNSP — CNS Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: FDA Grants Fast Track Designation To CNS Pharmaceuticals For Berubicin For The Treatment Of Recurrent Glioblastoma Multiforme

    Picture of CNS Pharmaceuticals logoCNS Pharmaceuticals
    29/06/2021 14:10
    June 29 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * FDA GRANTS FAST TRACK DESIGNATION TO CNS PHARMACEUTICALS
FOR
BERUBICIN FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA MULTIFORME

Source text for Eikon:  ID:nPn3HKl5ca 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CNS Pharmaceuticals

    See all news